Disparities in testicular cancer incidence, mortality, and place of death trends from 1999 to 2020: A comprehensive cohort study
Cancer Reports · 2023-10 · 6 (10)
DOI: 10.1002/cnr2.1880 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Reports, online erschienen am 16.08.2023. Verfasst von Beck O Gold und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Second Primary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Testicular cancer (TC) mortality rates have decreased over time, however it is unclear whether these improvements are consistent across all communities.
Aims
The aim of this study was to analyze trends in TC incidence, mortality, and place of death (PoD) in the United States between 1999–2020 and identify disparities across race, ethnicity, and geographic location. Methods and Results This cross‐sectional study used CDC WONDER and NAACCR, to calculate age‐adjusted rates of TC incidence and mortality, respectively. PoD data for individuals who died of TC were collected from CDC WONDER. Using Joinpoint analysis, longitudinal mortality trends were evaluated by age, race, ethnicity, US census region, and urbanization category. TC stage (localized vs metastatic) trends were also evaluated. Univariate and multivariate regression analysis identified demographic disparities for PoD. A total of 8,456 patients died of TC from 1999–2020. Average annual percent change (AAPC) of testicular cancer‐specific mortality (TCSM) remained largely stable (AAPC, 0.4; 95% CI −0.2 to 0.9; p = 0.215). Men ages 25–29 experienced a significant increase in TCSM (AAPC, 1.3, p = 0.003), consistent with increased metastatic testicular cancer‐specific incidence (TCSI) trend for this age group (AAPC, 1.6; p < 0.01). Mortality increased for Hispanic men (AAPC, 1.7, p < 0.001), with increased metastatic TCSI (AAPC, 2.5; p < 0.001). Finally, younger (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Sophia C Kamran
Förderung
- NCI NIH HHS
Zitieren
APA
Gold, B. O., Ghosh, A., Goldberg, S. I., Chino, F., Efstathiou, J. A., & Kamran, S. C. (2023). Disparities in testicular cancer incidence, mortality, and place of death trends from 1999 to 2020: A comprehensive cohort study. Cancer Reports, 6(10). https://doi.org/10.1002/cnr2.1880
Vancouver
Gold BO, Ghosh A, Goldberg SI, Chino F, Efstathiou JA, Kamran SC. Disparities in testicular cancer incidence, mortality, and place of death trends from 1999 to 2020: A comprehensive cohort study. Cancer Reports. 2023;6(10). doi:10.1002/cnr2.1880
BibTeX
@article{Gold2023,
author = {Gold, Beck O and Ghosh, Anushka and Goldberg, Saveli I and Chino, Fumiko and Efstathiou, Jason A and Kamran, Sophia C},
title = {Disparities in testicular cancer incidence, mortality, and place of death trends from 1999 to 2020: A comprehensive cohort study},
journal = {Cancer Reports},
year = {2023},
volume = {6},
number = {10},
doi = {10.1002/cnr2.1880}
}
EUVIMED